表紙
市場調査レポート

整形外科市場

Orthopedics Markets

発行 TriMark Publications 商品コード 172795
出版日 ページ情報 英文 283 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
整形外科市場 Orthopedics Markets
出版日: 2011年02月01日 ページ情報: 英文 283 Pages
概要

整形外科市場は医療機器分野で最も活気ある業界のひとつとして台頭してきました。世界の整形外科市場は年率5〜7%近くで成長しています。市場のリーダー5社が現在世界的に市場を独占し、年間売上は各社20億米ドル以上となっています。

当レポートでは、世界の整形外科市場をセグメント別に分析し、米国をはじめとする世界的企業のマーケティング、製造、開発活動、売上予測などをまとめ、概略下記の内容でお届けいたします。

第1章 概要

第2章 整形外科処置と製品概要

  • 本章の範囲
  • 股関節インプラント手術
  • 膝関節インプラント手術
  • 肩関節
  • 脊髄
  • 足・足首
  • 外傷
  • 関節鏡検査
  • 体外衝撃波療法
  • 骨折治癒における電気刺激
  • 整形外科インプラントに用いられる材料

第3章 整形外科市場分析

  • 本章の範囲
  • 整形外科業界
  • 市場促進因子
  • 医療機器メーカーの変化
  • 整形外科装置セグメントの概要
  • 世界の整形外科市場
  • 世界の整形外科再建市場
  • 世界の関節置換市場
  • 世界の骨折修復市場
  • 顎顔面再建
  • 世界のバイオメディカルメタル市場
  • 世界のオルソバイオロジクス市場
  • Medsurg装置市場
  • 世界の非侵襲性整形外科
  • 整形外科における資金調達シナリオ
  • 米国の整形外科市場
  • 米国の筋骨格製品市場
  • 米国の整形外科再建市場
  • 米国の腰痛市場
  • 米国の整形外科バイオマテリアル市場
  • 米国の脊椎製品環境
  • 米国の膝関節鏡検査
  • 米国の内視鏡外科製品市場
  • 米国の代用骨市場
  • 米国の整形外科バイオマテリアル市場
  • 米国の整形外科軟組織およびスポーツ医学市場
  • 米国の整形外科医
  • 米国のブレース・サポート市場
  • 欧州の整形外科
  • 中国の整形外科装置市場

第4章 企業プロファイル

付録

目次
Product Code: TMRORTH11-0201

Abstract

Orthopedics is a medical specialty that deals with the diagnosis and treatment of disorders and injuries to the skeletal system and the muscles, joints and ligaments associated with it. The orthopedics market has emerged as one of the most vibrant industries in the medical equipment sector. In the recent past, the orthopedics industry has witnessed major private equity transactions, several notable mergers and innovative product launches. As such, the orthopedics market has been experiencing a growth rate of nearly 5% to 7% annually. Five market leaders currently dominate the global market, each with about $2 billion or more in annual sales. The purpose of this TriMark Publications report is to provide a detailed analysis of the global market for orthopedics. The product segments covered in study include: reconstructive devices, fracture repair, arthroscopy/tissue repair, spinal implants/instrumentation, orthobiologics and other orthopedic products. The study analyzes almost all of the companies known to be marketing, manufacturing or developing orthopedic products in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company' s market position. Also provided in this review are detailed tables, charts and figures with past and projected sales data by geographic region for the U.S., EMEA (Europe, Middle East, Africa), Japan, the Pacific Rim, Canada and Latin America.

Table of Contents

1. Overview

  • 1.1. Statement of Report
  • 1.2. Scope of the Report
  • 1.3. Methodology
  • 1.4. Executive Summary

2. Overview of Selected Orthopedic Surgical Procedures and Products

  • 2.1. Scope of this Chapter
  • 2.2. Surgery for Hip Implants
    • 2.2.1. Cemented Hip Implants
    • 2.2.2. Porous Hip Implants
    • 2.2.3. Preparing for Hip Implant Surgery
    • 2.2.4. Hip Implant Surgery
    • 2.2.5. Market Leaders in Hip and Knee Implants
    • 2.2.6. Benefits of Hip and Knee Replacement
    • 2.2.7. Most Common Hip Disorders
    • 2.2.8. Total Hip Arthroplasty at the Global Level
  • 2.3. Surgery for Knee Implants
    • 2.3.1. Gender-Specific Knee
    • 2.3.2. Viscosupplementation for the Osteoarthritis of the Knee
    • 2.3.3. Synovial Injections and Efficacy
    • 2.3.4. Market Leaders in Knee Products
    • 2.3.5. Pricing Trends in Hip and Knee Implants
      • 2.3.5.1. Total Hips
      • 2.3.5.2. Partial Hips
    • 2.3.6. Knee Implants
  • 2.4. Shoulder Implants
    • 2.4.1. Reverse Shoulder Replacement
    • 2.4.2. Total Shoulder Replacement
    • 2.4.3. Rotator Cuff Repair
  • 2.5. Spine Anatomy
    • 2.5.1. Spine Disorders
    • 2.5.2. Spinal Implants
    • 2.5.3. Spinal Fusion Surgery
    • 2.5.4. Spinal Stabilization
    • 2.5.5. Common Indications for Spinal Surgery in the Elderly
    • 2.5.6. Average Reimbursement by Spinal Indication
    • 2.5.7. Medicare Reimbursements and Treatment Alternatives
    • 2.5.8. Lumbar Spine Fusion: Providers and Reimbursement in the U.S.
    • 2.5.9. Balloon Kyphoplasty
    • 2.5.10. Elderly Spine Patients
    • 2.5.11. Lumbar and Cervical Total Disc Replacement
    • 2.5.12. Indications for Total Disc Replacement
    • 2.5.13. Percutaneous Procedures
    • 2.5.14. Niche Markets in Spine
    • 2.5.15. Complication Rates in Posterior Lumbar Fusion
  • 2.6. Foot and Ankle
    • 2.6.1. Ankle Fusion and Ankle Replacement
    • 2.6.2. Deformities of Toes
    • 2.6.3. Plantar Fascial Fibromatosis
    • 2.6.4. Bunion
  • 2.7. Finger Disorders
    • 2.7.1. Carpal Tunnel Syndrome
  • 2.8. Tennis Elbow
  • 2.9. Trauma in Extremities
  • 2.10. Arthroscopy
  • 2.11. Extracorporeal Shockwave Therapy
  • 2.12. Bone Graft Materials
    • 2.12.1. Allograft-Based Bone Graft Substitutes
    • 2.12.2. Factor-Based Bone Graft Substitutes
    • 2.12.3. Cell-Based Bone Graft Substitutes
    • 2.12.4. Ceramic-Based Bone Graft Substitutes
    • 2.12.5. Polymer-Based Bone Graft Substitutes
  • 2.13. Electrical Stimulation in Fracture Healing
  • 2.14. Materials Used in Orthopedic Implants
    • 2.14.1. Implant Fabrication Process
    • 2.14.2. Post-Fabrication Coatings
    • 2.14.3. Forces Shaping the Implant Market
      • 2.14.3.1. A New Class of Materials
    • 2.14.4. Future Trends in Orthopedics

3. Orthopedics Market Analysis

  • 3.1. Scope of this Chapter
  • 3.2. Orthopedics Industry
  • 3.3. Market Drivers in Orthopedics
    • 3.3.1. Changing Lifestyle
    • 3.3.2. Aging Population
    • 3.3.3. Technology Advancements
    • 3.3.4. Implants as Effective Alternatives to Drug Therapy
  • 3.4. Changing Focus of Medical Device Companies
  • 3.5. Primacy of the Orthopedic Device Segment
  • 3.6. Global Orthopedics Market
    • 3.6.1. Market Leaders in Orthopedic Implants
    • 3.6.2. Orthopedics Market Segment Overview
    • 3.6.3. Global Orthopedics Market Leaders
    • 3.6.4. Global Orthopedics Market by Geography
    • 3.6.5. Future of the Global Orthopedics Market
    • 3.6.6. Global Spine Market
      • 3.6.6.1. Future Market for Spinal Implants
  • 3.7. Global Orthopedic Reconstruction Market
    • 3.7.1. Future of Orthopedic Reconstruction Market
    • 3.7.2. Global Trauma and Craniomaxillofacial Market
    • 3.7.3. Future of Global Trauma and Craniomaxillofacial Market
  • 3.8. Global Joint Replacement Market
  • 3.9. Global Market for Fracture Repair
    • 3.9.1. Patient Demographics in Bone Fractures
  • 3.10. Craniomaxillofacial Reconstruction
  • 3.11. Global Biomedical Metal Market
  • 3.12. Global Orthobiologics Market
    • 3.12.1. Spinal Fusion: 75% of All Bone Grafts
    • 3.12.2. Foot and Ankle Fusions
    • 3.12.3. Orthopedic Trauma
    • 3.12.4. Reconstruction
    • 3.12.5. Biologic Solutions in Sports Medicine
    • 3.12.6. Future of Global Orthobiologics Market
  • 3.13. Medsurg Equipment Market
    • 3.13.1. Global Endoscopy Market
  • 3.14. Global Market for Non-Invasive Orthopedics
  • 3.15. Funding Scenario in Orthopedics
  • 3.16. Orthopedics Market in the U.S.
    • 3.16.1. Reimbursement and Healthcare Costs in the U.S.
    • 3.16.2. Overspending on Orthopedics in the U.S.
  • 3.17. U.S. Market for Musculoskeletal Products
  • 3.18. U.S. Orthopedic Reconstruction Market
  • 3.19. U.S. Back Pain Market
  • 3.20. U.S. Market for Orthopedic Biomaterials
  • 3.21. Landscape for Spinal Products in the U.S.
    • 3.21.1. Reimbursement for Spinal Procedures
    • 3.21.2. Causes of Spinal Cord Injuries in the U.S.
    • 3.21.3. Most Common Spine Ailments in the U.S.
    • 3.21.4. Disc Displacements
      • 3.21.4.1. Degenerative Disc Disease
      • 3.21.4.2. Vertebral Dislocation
      • 3.21.4.3. Spondylosis
      • 3.21.4.4. Growing Spinal Revenue
      • 3.21.4.5. High Growth Rate by Large Companies
      • 3.21.4.6. Medicare' s Spine Surgery Burdens in the U.S.
      • 3.21.4.7. Common Indications for Spine Surgery in the U.S.
      • 3.21.4.8. Average Reimbursement by Indication
      • 3.21.4.9. Medical Reimbursement and Treatment Alternatives
      • 3.21.4.10. Comorbidities in Lumbar Fusion: Medicare vs. Private Pay
      • 3.21.4.11. Providers and Reimbursement for Lumbar Spine Fusion in the U.S
      • 3.21.4.12. Artificial Disc, Facet and Nucleus Replacement and Dynamic Stabilization
    • 3.21.5. U.S. Spine Market
  • 3.22. Total Knee Arthroplasty in the U.S.
  • 3.23. U.S. Market for Endoscopic Surgery Products
  • 3.24. Market for Bone Graft Substitutes in the U.S.
  • 3.25. U.S. Orthopedic Biomaterials Market
  • 3.26. U.S. Market for Orthopedic Soft Tissue and Sports Medicine
  • 3.27. Orthopedic Surgeons in the U.S.
  • 3.28. Orthopedic Brace and Support Market in the U.S.
  • 3.29. Orthopedics in Europe
  • 3.30. Orthopedic Device Market in China
    • 3.30.1. Growth Drivers
    • 3.30.2. Chinese Orthopedics Market Size and Growth
    • 3.30.3. Major Orthopedic Device Players in China

4. Company Profiles

  • 4.1. aap Implantate AG
    • 4.1.1. aap' s Bone Replacement Products
      • 4.1.1.1. PerOssal
      • 4.1.1.2. Ostim
      • 4.1.1.3. Cerabone
    • 4.1.2. Soft Tissue Regeneration
      • 4.1.2.1. AdconGel
      • 4.1.2.2. Jason
      • 4.1.2.3. Hynoval
    • 4.1.3. aap' s Cementing Techniques
      • 4.1.3.1. Easymix
      • 4.1.3.2. MicroAire Hi Speed Pulse Lavage System
    • 4.1.4. aap' s Trauma Products
      • 4.1.4.1. Angle-Stable Plates
      • 4.1.4.2. Proximal Humerus Plate
      • 4.1.4.3. Angle Stable Distal Radial Plate
      • 4.1.4.4. Trauma Shoulder System
  • 4.2. AlloSource
    • 4.2.1. AlloSource' s Selected Osteobiologics
      • 4.2.1.1. AlloFuse DBM Putty
      • 4.2.1.2. AlloSource' s Spinal Grafts
      • 4.2.1.3. Sports Medicine Grafts
  • 4.3. Alphatec Spine
    • 4.3.1. The Alphatec Solution
    • 4.3.2. Alphatec' s Business Performance
  • 4.4. Amedica/U.S. Spine
    • 4.4.1. Amedica/U.S. Spine' s Products
      • 4.4.1.1. Valeo C-Cervical Spacer
      • 4.4.1.2. Valeo TL-Lumbar Spacer
      • 4.4.1.3. Valeo PL-Lumbar Spacer
      • 4.4.1.4. Valeo OL-Lumbar Spacer
      • 4.4.1.5. Valeo AL-Lumbar Spacer
      • 4.4.1.6. Valeo CP-Cervical Plate System
      • 4.4.1.7. Valeo Concise-Anterior Cervical Plate System
      • 4.4.1.8. Valeo PS-Pedicle Screw System
      • 4.4.1.9. Valeo BP-Synthetic Bone Putty
  • 4.5. Anika Therapeutics, Inc.
    • 4.5.1. Anika' s Products
      • 4.5.1.1. Orthovisc
      • 4.5.1.2. Monovisc
      • 4.5.1.3. Orthovisc mini
  • 4.6. ApaTech
    • 4.6.1. Actifuse ABX
  • 4.7. Arteriocyte Medical Systems, Inc.
    • 4.7.1. Arteriocyte' s Role in Orthopedic Regenerative Medicine
  • 4.8. Artimplant
    • 4.8.1. Artimplant' s Product Portfolio and Market
      • 4.8.1.1. Resurfacing: Restoring the Joint Surface
      • 4.8.1.2. Reinforcement of Tissue
      • 4.8.1.3. Replenishment: Augmentation of Tissue Volume
  • 4.9. ArthoCare Corporation
    • 4.9.1. ArthoCare' s Arthroscopic Business Segment
    • 4.9.2. ArthoCare' s Spine Business Segment
    • 4.9.3. ArthoCare' s Spine Products
      • 4.9.3.1. SpineWand Product Line
      • 4.9.3.2. Parallax Product Line
  • 4.10. Ascension Orthopedics, Inc.
    • 4.10.1. Selected Products from Ascension
      • 4.10.1.1. PyroCarbon MCP
      • 4.10.1.2. PyroCarbon PIP
      • 4.10.1.3. Silicone PIP
      • 4.10.1.4. NuGrip CMC Implant
      • 4.10.1.5. Ascension Movement Hemi Great Toe System
  • 4.11. Aesculap
    • 4.11.1. Selected Products from Aesculap/B. Braun
      • 4.11.1.1. Bicontact Universal Hip System
      • 4.11.1.2. Metha Short Hip Stem
      • 4.11.1.3. Excia Hip Stem
      • 4.11.1.4. Prevision Modular Hip Revision Stem
      • 4.11.1.5. Plasmacup SC Acetabular Cup
      • 4.11.1.6. MIOS Minimally-Invasive Orthopedic Solutions
      • 4.11.1.7. e.motion Total Knee System
      • 4.11.1.8. Columbus Total Knee System
      • 4.11.1.9. EnduRo Rotating Hinge Knee System
      • 4.11.1.10. Univation Unicondylar Knee System
      • 4.11.1.11. Search Evolution Total Knee System
      • 4.11.1.12. MIOS Minimally-Invasive Orthopedic Solutions
  • 4.12. AxioMed Spine Corporation
    • 4.12.1. Freedom Lumbar Disc
  • 4.13. Biocomposites Ltd.
  • 4.14. Bacterin International, Inc.
  • 4.15. BioMimetic Therapeutics, Inc.
    • 4.15.1. BioMimetic' s Product Candidates
  • 4.16. BioSurface Engineering Technologies, Inc.
    • 4.16.1. Amplex
  • 4.17. Bone Biologics, Inc.
    • 4.17.1. UCB-1
    • 4.17.2. UCS-1
  • 4.18. BoneSupport AB
  • 4.19. Biomet, Inc.
    • 4.19.1. Biomet' s Products
    • 4.19.2. Reconstructive Products
      • 4.19.2.1. Knee Systems
      • 4.19.2.2. Hip Systems
    • 4.19.3. Extremity Systems
    • 4.19.4. Dental Reconstructive Devices
    • 4.19.5. Spinal Products
      • 4.19.5.1. Spine Fusion Stimulation Systems
      • 4.19.5.2. Spinal Fixation Systems
    • 4.19.6. Bone Substitute and Allograft Materials
  • 4.20. Bone Solutions, Inc.
    • 4.20.1. OsteoCrete Bone Void Filler
  • 4.21. Ceramisys Ltd.
    • 4.21.1. ReproBone
  • 4.22. Cerapedics, Inc.
  • 4.23. Collagen Matrix, Inc.
    • 4.23.1. OssiMend Bone Graft Matrix
    • 4.23.2. OssiMend Block Bone Graft Matrix
    • 4.23.3. OssiMend Putty Bone Graft Matrix
    • 4.23.4. DuraMatrix-Onlay Collagen Dura Substitute Membrane
    • 4.23.5. DuraMatrix Collagen Dura Substitute Membrane
    • 4.23.6. TenoMend Collagen Tendon Wrap
    • 4.23.7. OssiGuide Cancellous Granules
    • 4.23.8. OssiPatch Collagen Bone Healing Protective Sheet
    • 4.23.9. SynOss Synthetic Mineral
  • 4.24. Conmed Linvatec Corporation
    • 4.24.1. Conmed' s Arthroscopy Products
    • 4.24.2. Conmed' s Powered Surgical Instruments
    • 4.24.3. Conmed' s Electrosurgery Products
    • 4.24.4. Conmed' s Patient Care Products
    • 4.24.5. Conmed' s Endosurgery Products
    • 4.24.6. Conmed' s Endoscopy Products
    • 4.24.7. Conmed' s Business Performance
  • 4.25. Core Essence Orthopaedics, Inc.
    • 4.25.1. TAC-tite
    • 4.25.2. reVERTO Shape Memory Staple System
    • 4.25.3. SEG-WAY Endoscopic Guide System
    • 4.25.4. reNOVO Suture Anchor System
    • 4.25.5. PONTiS Endotendonous Repair System
  • 4.26. Corin Group PLC
  • 4.27. DePuy Spine, Inc.
    • 4.27.1. DePuy Spine' s Biologic Solutions
      • 4.27.1.1. Symphony Platelet Concentrate System
      • 4.27.1.2. Conduit TCP Granules
      • 4.27.1.3. Healos Bone Graft Replacement
      • 4.27.1.4. Healos Fx Injectable Bone Graft Replacement
      • 4.27.1.5. Overview of Other Products from DePuy Spine, Inc.
  • 4.28. DeRoyal, Inc.
    • 4.28.1. DeRoyal' s Orthopedic Product Portfolio
      • 4.28.1.1. Cervical Collars and Traction
      • 4.28.1.2. Clavicle Straps
      • 4.28.1.3. Shoulder Immobilizers
      • 4.28.1.4. Arm Slings and Elevators
      • 4.28.1.5. Elbow Supports and Sleeves
      • 4.28.1.6. Wrist and Thumb Splints
      • 4.28.1.7. Aluminum Splints
      • 4.28.1.8. Abdominal Binders and Rib Belts
      • 4.28.1.9. Knee Immobilizers
      • 4.28.1.10. Bucks Traction
      • 4.28.1.11. Post-Op Shoes
  • 4.29. DJO Finance, LLC (DJOFL)
    • 4.29.1. DJOFL' s Operating Segments
    • 4.29.2. DJOFL' s Products
    • 4.29.3. DJOFL' s Business Performance
  • 4.30. Etex Corporation
  • 4.31. Exactech, Inc.
    • 4.31.1. Exatech' s Products
      • 4.31.1.1. Knee Implants
      • 4.31.1.2. Hip Implants
      • 4.31.1.3. Biologics and Spine
      • 4.31.1.4. Extremities
      • 4.31.1.5. Other Products
    • 4.31.2. Exactech' s Business Performance
  • 4.32. Facet Solutions, Inc.
    • 4.32.1. Acadia Facet Replacement System
  • 4.33. Gentis, Inc.
    • 4.33.1. Gentis' Technology
  • 4.34. Genzyme Corporation
    • 4.34.1. Genzyme' s Biosurgery Unit Performance
  • 4.35. Geron Corporation
  • 4.36. Globus Medical, Inc.
  • 4.37. GMReis
  • 4.38. Graftys SA
  • 4.39. Inion Oy
  • 4.40. Integra LifeSciences Holdings Corporation
    • 4.40.1. Integra' s Orthopedic Products
      • 4.40.1.1. Nerve and Tendons
      • 4.40.1.2. Bone and Joint Fixation Devices and Instruments
      • 4.40.1.3. Bone Graft Substitutes for Extremity Reconstruction
      • 4.40.1.4. Spinal Fusion Devices
      • 4.40.1.5. Supplemental Fixation Systems
      • 4.40.1.6. Interbody/Vertebral Body Replacements
      • 4.40.1.7. OrthoBiologics
      • 4.40.1.8. Minimally-Invasive Solutions
    • 4.40.2. Integra' s Business Performance
  • 4.41. Interventional Spine, Inc.
  • 4.42. ISTO Technologies, Inc.
    • 4.42.1. InQu
    • 4.42.2. NuQu
    • 4.42.3. DeNovo ET
  • 4.43. K2M, Inc.
  • 4.44. Kasios
  • 4.45. Kensey Nash Corporation
  • 4.46. Kyphon, Inc.
  • 4.47. Lanx, Inc.
  • 4.48. LDR Holding Corporation
    • 4.48.1. ROI
    • 4.48.2. ROI-T
    • 4.48.3. SpineTune TL
    • 4.48.4. EasySpine
    • 4.48.5. ROI-A
    • 4.48.6. ROI-C
  • 4.49. LifeSpine, Inc.
  • 4.50. Medartis
  • 4.51. Medtronic, Inc.
    • 4.51.1. Medtronic' s Spinal Implant Products
  • 4.52. Mekanika, Inc.
  • 4.53. Mesoblast
    • 4.53.1. Mesoblast' s MPC Technology
    • 4.53.2. Mesoblast' s Cartilage Regeneration Technology
    • 4.53.3. Mesoblast' s Technology for Disc Regrowth
  • 4.54. MiMedx Group, Inc.
    • 4.54.1. HydroFix
    • 4.54.2. CollaFix
  • 4.55. Nanotherapeutics, Inc.
    • 4.55.1. Origen DBM
    • 4.55.2. NanoFUSE
  • 4.56. NovaBone Products, LLC
    • 4.56.1. NovaBone' s Products
      • 4.56.1.1. NovaBone
      • 4.56.1.2. NovaBone Putty
      • 4.56.1.3. NovaBone Particulate
      • 4.56.1.4. NovaBone Morsels
      • 4.56.1.5. NovaBone Dental Putty
      • 4.56.1.6. PerioGlas
  • 4.57. NuVasive, Inc.
    • 4.57.1. NuVasive' s Recent Product Introductions
    • 4.57.2. NuVasive Solutions
      • 4.57.2.1. Maximum Access Surgery (MAS)
      • 4.57.2.2. MAS-NeuroVision
      • 4.57.2.3. MAS-MaXcess
      • 4.57.2.4. MAS-Specialized Implants
      • 4.57.2.5. MAS-Biologics
    • 4.57.3. NuVasive' s Business Performance
  • 4.58. Olympus Terumo Biomaterials Corporation
  • 4.59. Orteq Sports Medicine
    • 4.59.1. Actifit
  • 4.60. Orthofix International, NV
    • 4.60.1. Orthofix' s Business Segments and Market Sectors
    • 4.60.2. Orthofix' s Products
  • 4.61. Orthomimetics Ltd.
    • 4.61.1. Chondriomimetic
  • 4.62. OrthoScan, Inc.
    • 4.62.1. OrthoScan FD
    • 4.62.2. OrthoScan UC
  • 4.63. Orthovita, Inc.
    • 4.63.1. Orthovita' s Patents and Proprietary Intellectual Property
    • 4.63.2. Orthovita' s Business Performance
  • 4.64. ossur hf
    • 4.64.1. Bracing and Supports
    • 4.64.2. Prosthetics
    • 4.64.3. Compression Therapy
    • 4.64.4. Ossur' s Business Performance in 2009
  • 4.65. Osteotech, Inc.
    • 4.65.1. Osteotech' s Products
    • 4.65.2. Osteotech' s Business Segments
  • 4.66. Pioneer Surgical Orthobiologics, Inc.
  • 4.67. ProChon Biotech Ltd.
    • 4.67.1. BioCart
  • 4.68. Ranier Technology
    • 4.68.1. Cadisc-L
    • 4.68.2. Cadisc-C
  • 4.69. ReGen Biologics, Inc.
    • 4.69.1. Menaflex
  • 4.70. RTI Biologics, Inc.
    • 4.70.1. RTI' s Products and Distributors
  • 4.71. Small Bone Innovations, Inc.
  • 4.72. Smith & Nephew
  • 4.73. SpinalKinetics
    • 4.73.1. M6 Artificial Disc
  • 4.74. Spinal Restorations, Inc.
    • 4.74.1. Biostat System
  • 4.75. Spine Smith, LP
  • 4.76. Soft Tissue Regeneration, Inc.
    • 4.76.1. STR' s Technology
  • 4.77. Stryker Corporation
    • 4.77.1. Stryker' s Product Sales
    • 4.77.2. Stryker' s Orthopedic Implants
      • 4.77.2.1. Stryker' s Hip Implant Systems
      • 4.77.2.2. Stryker' s Primary Femoral Hip Systems
      • 4.77.2.3. Stryker' s Primary Acetabular Systems
      • 4.77.2.4. Stryker' s Revision Hip Systems
      • 4.77.2.5. Stryker' s Resurfacing Hip Systems
      • 4.77.2.6. Stryker' s Knee Implant Systems
      • 4.77.2.7. Stryker' s Other Joint Replacement Products
      • 4.77.2.8. Stryker' s Bone Cement
      • 4.77.2.9. Stryker' s Trauma Implant Systems
      • 4.77.2.10. Stryker' s Spinal Implant Systems
      • 4.77.2.11. Craniomaxillofacial (CMF) Implant Systems
      • 4.77.2.12. OP-1/BMP-7
    • 4.77.3. Stryker' s MedSurge Equipments
    • 4.77.4. Stryker' s Business Performance
  • 4.78. Symmetry Medical, Inc.
    • 4.78.1. Symmetry' s Products
      • 4.78.1.1. Symmetry' s Implants
    • 4.78.2. Symmetry' s Instruments
    • 4.78.3. Symmetry' s Cases
    • 4.78.4. Symmetry' s Customers
    • 4.78.5. Symmetry' s Business Performance
  • 4.79. Synovis Life Technologies, Inc.
    • 4.79.1. Synovis' Biomaterial Products
    • 4.79.2. Synovis' Microsurgery Products
  • 4.80. Synthes, Inc.
    • 4.80.1. Synthes' Business Performance by Geography
    • 4.80.2. Trauma Products from Synthes
  • 4.81. ThermoGenesis Corporation
    • 4.81.1. AutoXpress Platform
    • 4.81.2. MarrowXpress
    • 4.81.3. BioArchive System
    • 4.81.4. Res-Q 60 BMC
    • 4.81.5. Thermoline
    • 4.81.6. CryoSeal Fibrin Sealant (CryoSeal) System
  • 4.82. TiGenix NV
    • 4.82.1. ChondroCelect
    • 4.82.2. Chondromimetic
    • 4.82.3. TGX003
    • 4.82.4. Stem Cells
  • 4.83. TissueGene, Inc.
    • 4.83.1. TissueGene' s Technology
  • 4.84. Tissue Genesis, Inc.
    • 4.84.1. Cell Isolation System
  • 4.85. Tornier, Inc.
  • 4.86. TranS1
    • 4.86.1. TranS1' s Solution
    • 4.86.2. The Impressive Performance of TranS1' s Business
  • 4.87. Velcura Therapeutics, Inc.
  • 4.88. Vertebron
    • 4.88.1. Vertebron PSS-Pedicle Screw System
    • 4.88.2. Vertebron SSP Semi-Constrained Cervical Plate
    • 4.88.3. ACIF-Anterior Cervical and PLIF-Posterior Lumbar (Allografts)
    • 4.88.4. PEEK Vertical Body Replacements Devices
    • 4.88.5. Cervical Motion Preservation (CMP)
  • 4.89. Wright Medical Group, Inc.
    • 4.89.1. Wright' s Products
    • 4.89.2. Wright' s Business Performance
  • 4.90. X-Spine Systems, Inc.
  • 4.91. Xylos Corporation
    • 4.91.1. Xylos' Technology Applications in Musculoskeletal Disorders
  • 4.92. Zimmer Holdings, Inc.
    • 4.92.1. Zimmer' s Customers
    • 4.92.2. Zimmer' s Products
      • 4.92.2.1. NexGen Complete Knee Solution
      • 4.92.2.2. Natural-Knee II System
      • 4.92.2.3. Gender Solutions Natural-Knee Flex System
      • 4.92.2.4. Innex Total Knee System
      • 4.92.2.5. Zimmer Unicompartmental Knee Systems
      • 4.92.2.6. Zimmer Patient-Specific Instruments
      • 4.92.2.7. Zimmer Segmental System
      • 4.92.2.8. Zimmer M/L Taper Hip Prosthesis with Kinectiv Technology
      • 4.92.2.9. Alloclassic (Zweymuller) Hip System
      • 4.92.2.10. CLS Spotorno Hip System
      • 4.92.2.11. Fitmore Hip Stem
      • 4.92.2.12. VerSys Hip System
      • 4.92.2.13. Continuum Acetabular System, Trilogy IT Acetabular System and Allofit IT Alloclassic Acetabular System
      • 4.92.2.14. Zimmer MMC Cup
      • 4.92.2.15. Trilogy Acetabular System
      • 4.92.2.16. Bigliani/Flatow Complete Shoulder Solution Family
      • 4.92.2.17. Trabecular Metal Glenoid
      • 4.92.2.18. Trabecular Metal Reverse Shoulder System
      • 4.92.2.19. Anatomical Shoulder System
      • 4.92.2.20. Coonrad/Morrey Total Elbow
      • 4.92.2.21. Tapered Screw-Vent Implant System
      • 4.92.2.22. AdVent Implant System
      • 4.92.2.23. Tapered SwissPlus Implant System
      • 4.92.2.24. Zimmer Hex-Lock Contour Abutment and Restorative Products
      • 4.92.2.25. Puros Allograft Products
      • 4.92.2.26. Dynesys Dynamic Stabilization System
      • 4.92.2.27. PathFinder Minimally-Invasive Pedicle Screw System
      • 4.92.2.28. Sequoia Pedicle Screw System
      • 4.92.2.29. Ardis Interbody System
      • 4.92.2.30. Trinica Select Anterior Cervical Plating System
      • 4.92.2.31. Biological Products
      • 4.92.2.32. Wallis Posterior Dynamic Stabilization System
      • 4.92.2.33. Zimmer Natural Nail System
      • 4.92.2.34. NCB Polyaxial Locking Plate System
      • 4.92.2.35. Zimmer Periarticular Locking Plate System
      • 4.92.2.36. Zimmer Universal Locking System
      • 4.92.2.37. Zimmer Cable-Ready System
      • 4.92.2.38. Palacos Bone Cement
      • 4.92.2.39. Hi-Fatigue Bone Cement
      • 4.92.2.40. Automatic Tourniquet Systems (A.T.S.)
      • 4.92.2.41. Pulsavac Plus, Pulsavac Plus AC and Pulsavac Plus LP Wound Debridement System
      • 4.92.2.42. Zimmer Blood Reinfusion System (ZBRS) and Hemovac Blood Management Systems
    • 4.92.3. Zimmer' s Research and Development

APPENDIX

  • Appendix 1: Osteoporosis
  • Appendix 1.1: Osteoporosis-General
  • Appendix 1.2: Osteoporosis in Men
  • Appendix 1.3: Hip Fracture
  • Appendix 1.4: Vertebral Fracture
  • Appendix 1.5: Key Statistics for Europe
  • Appendix 1.6: Key Statistics for North America
  • Appendix 1.7: Key Statistics for Latin America
  • Appendix 1.8: Key Statistics for Middle East/North Africa
  • Appendix 1.9: Key Statistics for Asia
  • Appendix 1.10: Key Statistics for Oceania
  • Appendix 2: Statistics and Facts about Orthopedics and Orthopedic Practices in the U.S.
  • Appendix 3: Advances in Internal Bone Fixation
  • Appendix 3.1: Wires and Cables in Revision Surgery
  • Appendix 3.2: Problems from Broken Metal Cerclage Wires to Patients
  • Appendix 3.3: New Product Replacing Cerclage Cables
  • Appendix 4: Spinal Cord Injury Facts and Statistics
  • Appendix 5: Facts on Orthopedics, Clinical Trials, and Regulatory and Reimbursement Issues
  • Appendix 5.1: Clinical Trial Facts
  • Appendix 5.2: Clinical Trial Enrollment
  • Appendix 5.3: Clinical Trial Participants
  • Appendix 5.4: Clinical Trial Spending and Other Facts
  • Appendix 5.5: Musculoskeletal Pharma/Biologic Facts
  • Appendix 5.6: Regulatory Facts
  • Appendix 5.7: 510(k) Applications
  • Appendix 5.8: Investigational Device Exemption and Premarket Approval Application (PMA)
  • Appendix 5.9: Reimbursement Facts
  • Appendix 5.9.1: National Healthcare Spending in the U.S.
  • Appendix 5.9.2: Reimbursement
  • Appendix 5.9.3: Medicare/Medicaid
  • Appendix 5.9.4: Insurance
  • Appendix 6: Medicare Rule and its Impact on Orthopedic Technology Firms
  • Appendix 6.1: Ills of the U.S. Orthopedics Market
  • Appendix 6.2: Current Orthopedics Business Environment

INDEX OF FIGURES

  • Figure 2.1: Trends in Implant Price, Physician and Hospital Medicare Payment, 1991 and 2010
  • Figure 2.2: Trend in Total and Femoral Resurfacing Hip Procedures, 2005-2009
  • Figure 2.3: Percent Market Share of Coated Hip Stems by Company, 2009
  • Figure 2.4: Percent Market Share of Uncoated Femur/Poly Liner Constructs by Company, 2009
  • Figure 2.5: Percent of Cases by Construct Type, 2008
  • Figure 2.6: Percent of Cases by Knee Implant Construct Type, 2008
  • Figure 2.7: Lumbar TDR Revenue, 2007-2015
  • Figure 2.8: Cervical TDR Revenue, 2007-2015
  • Figure 2.9: Common Primary Diagnoses Associated with Inpatient Decompression Procedures
  • Figure 2.10: Percutaneous Discectomy Procedures by Site of Care
  • Figure 2.11: Percent Distribution of Spinal Deformity Diagnoses
  • Figure 2.12: Usage of Instrumentation in Lumbar Fusion
  • Figure 2.13: Most Common Complications from Posterior Lumbar Fusion in Males
  • Figure 2.14: Leading Companies in Foot and Ankle Surgical Products
  • Figure 2.15: Percent Ankle Fusion and Ankle Replacement Procedures in the U.S.
  • Figure 2.16: Progression of Bunion Disorder in Males and Females, 2004-2010
  • Figure 2.17: Carpal Tunnel Syndrome Occurrences by Gender
  • Figure 2.18: Common Associated Diagnoses Treated by ESWT Procedure
  • Figure 3.1: Growth of North American Population Aged 65 and Over, 2010-2020
  • Figure 3.2: Growth of Western European Population Aged 65 and Over, 2010-2020
  • Figure 3.3: Life Expectancy in North America, 2010-2020
  • Figure 3.4: Top Seven Medical Device Segments in the U.S., 2009
  • Figure 3.5: Percent Market Share of the Sub-Sectors of Orthopedics, 2009
  • Figure 3.6: Percent Global Market for Orthopedics by Product Segment, 2009
  • Figure 3.7: Global Orthopedics Market by Company, 2009
  • Figure 3.8: Percent Global Orthopedics Market by Geography, 2009
  • Figure 3.9: Global Market for Orthopedics, 2009-2016
  • Figure 3.10: Global Spinal Market Share by Company, 2009
  • Figure 3.11: Global Market for Spinal Implants, 2009-2016
  • Figure 3.12: Global Orthopedics Reconstructive Market Share by Company, 2009
  • Figure 3.13: Market for Orthopedic Reconstruction Devices, 2009-2016
  • Figure 3.14: Global Trauma and Craniomaxillofacial Market Share by Company, 2009
  • Figure 3.15: Global Market for Trauma and Craniomaxillofacial Products, 2009-2016
  • Figure 3.16: Market Share in Global Joint Replacement by Company, 2009
  • Figure 3.17: Percent Global Fracture Repair Market by Segment, 2009
  • Figure 3.18: Global Fracture Repair Market Share by Company, 2009
  • Figure 3.19: Fractures by Patient' s Age
  • Figure 3.20: Global Market Share of Craniomaxillofacial Products by Market Leaders, 2009
  • Figure 3.21: Growth of Global Surgical Instruments Market, 2009-2015
  • Figure 3.22: Global Orthobiologics Market Share by Company, 2009
  • Figure 3.23: Global Market for Orthobiologic Products, 2009-2016
  • Figure 3.24: Global Orthopedic Operating Room Equipment Market Share by Company, 2009
  • Figure 3.25: Global Endoscopy Market by Company, 2009
  • Figure 3.26: Global Market for Non-Invasive Orthopedics, 2009-2016
  • Figure 3.27: Percent Breakdown of Costs for Hip/Knee Replacement Surgeries in the U.S., 2009
  • Figure 3.28: Percent U.S. Market for Musculoskeletal Products, 2009
  • Figure 3.29: Percent U.S. Orthopedic Reconstructive Products Market, 2009
  • Figure 3.30: Percent U.S. Fixation Market, 2009
  • Figure 3.31: U.S. Spinal Products Market, 2009
  • Figure 3.32: U.S. Spinal Products Market, 2009-2016
  • Figure 3.33: U.S. Market for Back Pain Drugs, 2008-2018
  • Figure 3.34: U.S. Market for Biomaterials in Orthopedics, 2009-2016
  • Figure 3.35: Spine Company Market Share Summary, 2010
  • Figure 3.36: Spine Diagnoses in People Younger Than 65 Years of Age in the U.S.
  • Figure 3.37: Causes of Spinal Cord Injuries
  • Figure 3.38: Lumbar Fusion by Approach
  • Figure 3.39: Primary Inpatient Procedures in Treating Lumbar Spinal Stenosis
  • Figure 3.40: Incidence of Diabetes: Medicare Population and Private Pay Population
  • Figure 3.41: Average Charges per Region
  • Figure 3.42: Payment Distribution in Total Knee Replacement
  • Figure 3.43: Growth of Endoscopic Surgery Products in the U.S., 2009-2014
  • Figure 3.44: U.S. Market for Orthopedic Biomaterials, 2009-2016
  • Figure 3.45: U.S. Market for Soft Tissue and Sports Medicine, 2009-2016
  • Figure 3.46: Percent of Orthopedic Surgeons by Sub-Specialties, 2009
  • Figure 3.47: U.S. Market for Orthopedic Braces and Supports, 2005 and 2009
  • Figure 3.48: Orthopedics Reconstructive Market Leaders in Europe, 2008
  • Figure 3.49: European Trauma Market Share by Company, 2008
  • Figure 3.50: Size of Aging Population (65+) in Selected Countries, 2008
  • Figure 3.51: Prevalence of Arthritis in Selected Countries, 2008
  • Figure 3.52: Growth of Chinese Orthopedics Market, 2006-2009
  • Figure 4.1: Alphatec' s Business Performance, 2005-2009
  • Figure 4.2: Biomet' s Percent Business Performance by Product Category, 2009
  • Figure 4.3: Conmed' s Business Performance, 2005-2009
  • Figure 4.4: Exactech' s Overall Business Performance, 2005-2009
  • Figure 4.5: Integra' s Overall Business Performance, 2005-2009
  • Figure 4.6: Medtronic' s Percent Revenue by Operating Segments, 2010
  • Figure 4.7: NuVasive' s Business Growth, 2005-2009
  • Figure 4.8: Orthofix' s Overall Business Performance, 2005-2009
  • Figure 4.9: Orthovita' s Business Performance, 2005-2009
  • Figure 4.10: Stryker' s Overall Business Performance, 2005-2009
  • Figure 4.11: Synthes' Percent Market Share by Geography, 2009
  • Figure 4.12: TranS1' s Impressive Growth in Business, 2005-2009
  • Figure 4.13: Wright' s Overall Business Performance, 2005-2009
  • Figure 4.14: Zimmer' s Percent Business Performance by Geography, 2009
  • Figure A5.1: Share of Clinical Trial Funding by Source, 2009
  • Figure A5.2: Clinical Study Participants' Primary Concerns
  • Figure A5.3: Factors Impacting Clinical Study Participation
  • Figure A5.4: Capital Raised by Device Companies for PMA and 510k Approvals, 2005-2009
  • Figure A5.5: Total FDA PMA Submissions and Approvals, 2004-2009
  • Figure A6.1: Percent Change in Medicare Payment According to 2010 IPPS Rule
  • Figure A6.2: Economic Inequality Between Orthopedic Surgeon and Sales Representative, 2009
  • Figure A6.3: Percent Generic and Brand Name Prescriptions, 1984 and 2009

INDEX OF TABLES

  • Table 2.1: Selected Hip Products from the Top Two Market Leaders
  • Table 2.2: Most Common Large Joint Disorders: Disorders of the Hip
  • Table 2.3: Available Viscosupplements in the Market
  • Table 2.4: Injections and Following Procedures, 2004 and 2005
  • Table 2.5: Cost of Synovial Injections
  • Table 2.6: Knee Products from the Zimmer
  • Table 2.7: Change in Hip and Knee Implant List Prices, 2009 and 2010
  • Table 2.8: Total Hips/Resurfacing Prices by Manufacturer and Implant Type, 2009
  • Table 2.9: Partial Hips Prices by Manufacturer and Implant Type, 2009
  • Table 2.10: Knee Prices by Manufacturer and Implant Type, 2009
  • Table 2.11: Case Share of Total Hip Implant Assemblies, 2009
  • Table 2.12: Change in Femoral Resurfacing List Prices, 2009 and 2010
  • Table 2.13: Change in Metal-on-Metal Hip Implant List Prices, 2009 and 2010
  • Table 2.14: Change in Ceramic-on-Ceramic List Prices, 2009 and 2010
  • Table 2.15: Change in Coated Stem Poly Liner Hip Implant List Price, 2009 and 2010
  • Table 2.16: Case Shares of Partial Hip Implant Assemblies, 2009
  • Table 2.17: Change in Bipolar Hip Implant List Prices, 2009 and 2010
  • Table 2.18: Change in Modular Endoprostheses List Prices, 2009 and 2010
  • Table 2.19: Change in Coated Knee Implant List Prices, 2009 and 2010
  • Table 2.20: Change in Uncoated Knee Implant List Prices, 2009 and 2010
  • Table 2.21: Change in Hybrid Knee Implant List Prices, 2009 and 2010
  • Table 2.22: Change in Knee with All Poly Tibia List Prices, 2009 and 2010
  • Table 2.23: Change in Unicondylar Knee Implant List Prices, 2009 and 2010
  • Table 2.24: Top Five Shoulder-Related Diagnoses and the Baby Boomer Population
  • Table 2.25: Pedicle-Based Motion Preservation Devices and Their Indications
  • Table 2.26: Primary Inpatient Diagnoses of Spinal Disorders
  • Table 2.27: Average Reimbursement for Spine Indications
  • Table 2.28: Spinal Procedure Reimbursements
  • Table 2.29: Common Providers of Posterior Lumbar Fusion in Elderly Patients
  • Table 2.30: VCF Treatment by Site of Care and Levels Treated
  • Table 2.31: Age Ranges of the Most Common Spine Diagnoses
  • Table 2.32: Procedure Volumes for Patients More Than 64 Years of Age, 2007 and 2009
  • Table 2.33: TDR and Spine Fusion Primary Diagnoses
  • Table 2.34: Deformities of Toes Diagnoses, 2004-2007
  • Table 2.35: Average Charges for Toe Deformities
  • Table 2.36: Procedures for Treating Plantar Fascial Fibromatosis
  • Table 2.37: Percent Treatment Options for Tennis Elbow
  • Table 2.38: Most Common Fracture Diagnoses in Extremities, 2004-2007
  • Table 2.39: Bone Graft Substitutes
  • Table 3.1: Musculoskeletal Diagnoses Delineated by Age
  • Table 3.2: Global Orthopedic Product Sales by Market Segment and Geography, 2009
  • Table 3.3: Key Market Players in Orthopedic Implants
  • Table 3.4: Orthopedic Companies with Their Sales and Product Lines, 2009
  • Table 3.5: Global Market for Orthopedics by Product Segment, 2009
  • Table 3.6: Global Orthopedics Market by Company, 2009
  • Table 3.7: Global Orthopedic Market by Geography, 2009
  • Table 3.8: Global Market for Non-Invasive Orthopedics, 2009
  • Table 3.9: Orthopedics Companies (Excluding Spine and Hip/Knee) and Funding Received, 2008
  • Table 3.10: U.S. Healthcare Spending vs. Orthopedics Breakout, 2000-2009
  • Table 3.11: Industry EBITDA Margins, 2009
  • Table 3.12: Differences Between Pharma and Orthopedic Product Cycles
  • Table 3.13: Spinal Products Launched or in Clinical Studies in the Last Few Years
  • Table 3.14: Spine Company Market Share by Company, 2010
  • Table 3.15: Spine Implant and Related Biologics Industry Revenue, 2007-2012
  • Table 3.16: Spine Company Market Share, 2007-2012
  • Table 3.17: Reimbursement for Spinal Procedures, 2008-2010
  • Table 3.18: The Aging Spine in the U.S. Population, 2010-2050
  • Table 3.19: Spine Disorders as a Percentage of Common Diagnoses
  • Table 3.20: Quarterly and Estimated Annual Sales Revenue for Spine Product Companies, 2008-2010
  • Table 3.21: Primary Inpatient Diagnoses
  • Table 3.22: Average Reimbursement for Spine Indications
  • Table 3.23: Procedure Reimbursement
  • Table 3.24: Common Providers of Post-Lumbar Fusions in Aged Patients (ICD-9 Code 81.08)
  • Table 3.25: Artificial Disc Landscape
  • Table 3.26: Facet and Nucleus Replacement Landscape
  • Table 3.27: Dynamic Stabilization Landscape
  • Table 3.28: State TKA Rank by Volume in the U.S.
  • Table 3.29: U.S. Market for Bone Graft Substitutes, 2008 and 2009
  • Table 3.30: Leading Players in the Orthopedics Market in China, 2009
  • Table 3.31: Leading Players in the Spine Market in China, 2009
  • Table 4.1: Alphatec' s Current Products, 2009
  • Table 4.2: Products from U.S. Spine
  • Table 4.3: Artimplant' s Products and Projects, 2009
  • Table 4.4: ArthoCare' s Sports Medicine Products
  • Table 4.5: Biocomposites Ltd.' s Products
  • Table 4.6: Products from Bacterin International, Inc.
  • Table 4.7: BioMimetic' s Clinical Study Programs and Product Candidates, 2009
  • Table 4.8: Advantages and Disadvantages of Current Therapies
  • Table 4.9: BoneSupport' s Products
  • Table 4.10: Biomet' s Business Performance by Geography, 2007-2009
  • Table 4.11: Biomet' s Business Performance by Product Category, 2007-2009
  • Table 4.12: Conmed' s Arthroscopy Products, 2009
  • Table 4.13: Conmed' s Powered Surgical Instruments, 2009
  • Table 4.14: Conmed' s Electrosurgery Products, 2009
  • Table 4.15: Conmed' s Patient Care Products, 2009
  • Table 4.16: Conmed' s Endosurgery Products, 2009
  • Table 4.17: Conmed' s Endoscopy Products, 2009
  • Table 4.18: Corin' s Business Performance by Geography and Product Type, 2008 and 2009
  • Table 4.19: DePuy' s Other Products in Orthopedics
  • Table 4.20: DJOFL' s Domestic Rehabilitation Products, 2009
  • Table 4.21: DJOFL' s Domestic Surgical Implant Products, 2009
  • Table 4.22: DJOFL' s Business Performance, 2008 and 2009
  • Table 4.23: Orthopedic Products from Etex
  • Table 4.24: Exactech' s Business Performance by Product Line, 2007-2009
  • Table 4.25: Overview of Genzyme' s Biosurgery Products
  • Table 4.26: Genzyme' s Business in Biosurgery Products, 2008 and 2009
  • Table 4.27: Geron' s hESC-Derived Product Candidates for Orthopedic Applications
  • Table 4.28: Globus' Product Portfolio
  • Table 4.29: GMReis' Spine, Orthopedic and Biologic Products
  • Table 4.30: Products from Graftys SA
  • Table 4.31: Inion' s Product Portfolio
  • Table 4.32: Integra' s Revenue by Business Segment, 2007-2009
  • Table 4.33: Products from Interventional Spine
  • Table 4.34: Orthopedic Products from K2M
  • Table 4.35: Products from Kasios
  • Table 4.36: Kensey Nash' s Orthopedic Products
  • Table 4.37: Kyphon' s Orthopedic Products
  • Table 4.38: Products from Lanx
  • Table 4.39: Orthopedic Products from LifeSpine
  • Table 4.40: Medartis' Product Portfolio
  • Table 4.41: Medtronic' s Net Sales of Spinal Products, 2008-2010
  • Table 4.42: Mekanika' s Products
  • Table 4.43: Nanotherapeutics' Product Pipeline
  • Table 4.44: Products from Olympus Terumo Biomaterial Corporation
  • Table 4.45: Orthofix' s Business Performance by Business Segment, 2007-2009
  • Table 4.46: Orthofix' s Business Performance by Product Type, 2007-2009
  • Table 4.47: Orthofix' s Products and Primary Applications
  • Table 4.48: Orthovita' s Patented Products, 2010
  • Table 4.49: ossur' s Business Performance by Geography, 2009
  • Table 4.50: Osteotech' s Products
  • Table 4.51: Osteotech' s Business by Business Segment, 2007-2009
  • Table 4.52: Osteotech' s Business by Geography, 2007-2009
  • Table 4.53: Overview of Pioneer' s Spine Products
  • Table 4.54: RTI' s Business Performance, 2007-2009
  • Table 4.55: RTI' s Products and Distributors
  • Table 4.56: Orthopedic Products from Small Bone Innovations
  • Table 4.57: Smith & Nephew' s Orthopedic Products
  • Table 4.58: Spine Smith' s Product Portfolio
  • Table 4.59: Stryker' s Business Performance by Domestic/International/Business Segment, 2007-2009
  • Table 4.60: Symmetry' s Business Performance by Product Category, 2008 and 2009
  • Table 4.61: Synovis' Business Performance by Product Line, 2007-2009
  • Table 4.62: Synthes' Business Performance by Geography, 2009
  • Table 4.63: Products from Tornier, Inc.
  • Table 4.64: Velcura' s Product Pipeline
  • Table 4.65: Wright' s Products, 2009
  • Table 4.66: Wright' s Business Performance by Product Line, 2008 and 2009
  • Table 4.67: X-Spine' s Orthopedic Products
  • Table 4.68: Zimmer' s Orthopedics Business by Geography, 2005-2009
  • Table 4.69: Zimmer' s Global Business by Product Category and Region, 2008 and 2009
  • Table 4.70: Global Market and Zimmer' s Market Share, 2009
  • Table A3.1: Number of Hip Arthroplasties in the U.S., 2010 and 2030
  • Table A3.2: Number of Fractures during Hip Replacement Surgeries, 2010 and 2030
  • Table A3.3: Number of Fractures in the U.S., 2006
Back to Top